Alice P Chen, M.D.
National Cancer Institute (NCI)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Registry trials as an overall official
18
all conditions, ClinicalTrials.gov
NIH grants tied to them
0
NIH RePORTER
Trial papers in non-small cell lung cancer
0
PubMed author-name match
Trials
Studies that name Alice P Chen, M.D. as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 11:53 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04449549 · Rapid Analysis and Response Evaluation of Combination Anti-Neoplastic Agents in Rare Tumors (RARE CANCER) Trial: RARE 1 Nilotinib and PaclitaxelNational Cancer Institute (NCI) · recruiting · Neoplasms · principal investigator
- N/ANCT03269578 · Sample Collection and Tracking for the Developmental Therapeutics ClinicNational Cancer Institute (NCI) · recruiting · Neoplasms, Lymphoma · principal investigator
- Ph1NCT03030417 · Indenoisoquinoline LMP744 in Adults With Relapsed Solid Tumors and LymphomasNational Cancer Institute (NCI) · completed · Solid Tumors, Lymphoma · principal investigator
- Ph1NCT02723864 · Veliparib (ABT-888), an Oral PARP Inhibitor, and VX-970, an ATR Inhibitor, in Combination With Cisplatin in People With Refractory Solid TumorsNational Cancer Institute (NCI) · completed · Neoplasms · principal investigator
- Ph1NCT02379416 · Combination Nilotinib and Paclitaxel in Adults With Relapsed Solid TumorsNational Cancer Institute (NCI) · completed · Solid Tumors · principal investigator
- Ph1NCT02211755 · Trial of the Combination of Bortezomib and Clofarabine in Adults With Relapsed Solid TumorsNational Cancer Institute (NCI) · completed · Neoplasms, Myelodysplastic Syndromes, Lymphomas · principal investigator
- Ph1NCT02192541 · Ganetespib and Ziv-Aflibercept in Refractory Gastrointestinal Carcinomas, Non-Squamous Non-Small Cell Lung Carcinomas, Urothelial Carcinomas, and SarcomasNational Cancer Institute (NCI) · terminated · Neoplasms · principal investigator
- Ph1/Ph2NCT01989546 · Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA MutationsNational Cancer Institute (NCI) · completed · Advanced Ovarian Cancer, Primary Peritoneal Cancer, Advanced Breast Cancer · principal investigator
- Ph1/Ph2NCT01851369 · TRC102 and Temozolomide for Relapsed Solid Tumors and LymphomasNational Cancer Institute (NCI) · completed · Lymphomas, Solid Tumors, NSCLC · principal investigator
- Ph1NCT01794104 · Indenoisoquinoline LMP400 for Advanced Solid Tumors and LymphomasNational Cancer Institute (NCI) · completed · Neoplasm, Lymphoma · principal investigator
- Ph2NCT01755195 · Cabozantinib for Adults With Advanced Soft Tissue SarcomaNational Cancer Institute (NCI) · completed · Refractory Soft Tissue Sarcomas · principal investigator
- Ph1NCT01581541 · PU-H71 in Patients With Solid Tumors and Low-Grade Non-Hodgkin's Lymphoma That Have Not Responded to Standard TreatmentNational Cancer Institute (NCI) · terminated · Solid Tumors, Lymphoma · principal investigator
- Ph1NCT01468922 · Pazopanib and ARQ 197 for Advanced Solid TumorsNational Cancer Institute (NCI) · completed · Solid Tumor · principal investigator
- Ph2NCT01391962 · Sunitinib or Cediranib for Alveolar Soft Part SarcomaNational Cancer Institute (NCI) · completed · Sarcoma, Alveolar Soft Part · principal investigator
- Ph1NCT01273168 · Endoxifen in Adults With Hormone Receptor Positive Solid TumorsNational Cancer Institute (NCI) · completed · Hormone Receptor-Positive Breast, Gynecologic, Desmoid · principal investigator
- Ph1NCT01246102 · AT13387 in Adults With Refractory Solid TumorsNational Cancer Institute (NCI) · completed · Solid Tumors, Breast Cancer · principal investigator
- Ph1NCT01051635 · A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and LymphomasNational Cancer Institute (NCI) · completed · Neoplasms, Lymphoma · principal investigator
- Ph2NCT00942877 · Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part SarcomaNational Cancer Institute (NCI) · completed · Sarcoma, Alveolar Soft Part · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 11:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in non-small cell lung cancer.